Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 183

Similar articles for PubMed (Select 11035591)

1.

Hepatocellular carcinoma and non-Hodgkin lymphoma in a patient with chronic hepatitis C and cirrhosis.

Suriawinata A, Ye MQ, Emre S, Strauchen J, Thung SN.

Arch Pathol Lab Med. 2000 Oct;124(10):1532-4.

PMID:
11035591
2.

Antiviral therapy: why does it fail in HCV-related chronic hepatitis?

Masarone M, Persico M.

Expert Rev Anti Infect Ther. 2011 May;9(5):535-43. doi: 10.1586/eri.11.10. Review.

PMID:
21609265
3.

Detection of hepatitis C virus RNA in hepatocellular carcinoma by in situ hybridization.

Tang L, Tanaka Y, Enomoto N, Marumo F, Sato C.

Cancer. 1995 Dec 1;76(11):2211-6.

PMID:
8635023
4.

Survival outcomes in liver transplantation for hepatocellular carcinoma, comparing impact of hepatitis C versus other etiology of cirrhosis.

Bozorgzadeh A, Orloff M, Abt P, Tsoulfas G, Younan D, Kashyap R, Jain A, Mantry P, Maliakkal B, Khorana A, Schwartz S.

Liver Transpl. 2007 Jun;13(6):807-13.

5.

Killer cell immunoglobulin-like receptor genotype and killer cell immunoglobulin-like receptor-human leukocyte antigen C ligand compatibility affect the severity of hepatitis C virus recurrence after liver transplantation.

de Arias AE, Haworth SE, Belli LS, Burra P, Pinzello G, Vangeli M, Minola E, Guido M, Boccagni P, De Feo TM, Torelli R, Cardillo M, Scalamogna M, Poli F.

Liver Transpl. 2009 Apr;15(4):390-9. doi: 10.1002/lt.21673.

6.

Comparison of surgical outcomes for hepatocellular carcinoma in patients with hepatitis B versus hepatitis C: a western experience.

Roayaie S, Haim MB, Emre S, Fishbein TM, Sheiner PA, Miller CM, Schwartz ME.

Ann Surg Oncol. 2000 Dec;7(10):764-70.

PMID:
11129425
7.

Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis.

Mazzaferro V, Regalia E, Doci R, Andreola S, Pulvirenti A, Bozzetti F, Montalto F, Ammatuna M, Morabito A, Gennari L.

N Engl J Med. 1996 Mar 14;334(11):693-9.

9.

[Liver transplantation in a patient with cirrhosis and an uncontrolled extra-hepatic infectious focus].

Joomaye Z, Perney P, Pageaux GP, Perrigault PF, Souche B, Fabre JM, Domergue J, Le Quellec A, Blanc F.

Gastroenterol Clin Biol. 2001 Dec;25(12):1112-3. French. No abstract available.

10.

Prevalence of hepatitis C antibody in patients with chronic liver disease and hepatocellular carcinoma in Korea.

Park BC, Han BH, Ahn SY, Lee SW, Lee DH, Lee YN, Seo JH, Kim KW.

J Viral Hepat. 1995;2(4):195-202.

PMID:
7489347
11.

High TT virus load as an independent factor associated with the occurrence of hepatocellular carcinoma among patients with hepatitis C virus-related chronic liver disease.

Tokita H, Murai S, Kamitsukasa H, Yagura M, Harada H, Takahashi M, Okamoto H.

J Med Virol. 2002 Aug;67(4):501-9.

PMID:
12115995
12.

[Concurrent development of non-Hodgkin lymphoma and hepatocellular carcinoma in patient with chronic hepatitis C].

Malikhova OA, Tumanian AO, Ugniadze GV, Storozhakov GI, Lepkov SV.

Eksp Klin Gastroenterol. 2013;(7):44-8. Russian. No abstract available.

PMID:
24772876
13.

How can we treat a patient with liver cirrhosis (hepatitis C virus), hepatocellular carcinoma, and synchronous colon cancer?

Antoniou E, Mantas D, Paraskeva P, Dimitroulis D, Smyrnis A, Nikitakis N, Labadariou A, Tsavaris N, Vernicos P, Kostakis A.

Transplant Proc. 2012 Nov;44(9):2745-7. doi: 10.1016/j.transproceed.2012.09.003.

PMID:
23146511
15.
16.

Aberrant composition of the dendritic cell population in hepatic lymph nodes of patients with hepatocellular carcinoma.

Tang TJ, Vukosavljevic D, Janssen HL, Binda RS, Mancham S, Tilanus HW, Ijzermans JN, Drexhage H, Kwekkeboom J.

Hum Pathol. 2006 Mar;37(3):332-8.

PMID:
16613328
17.

Hepatitis B virus DNA integration in hepatocellular carcinoma after interferon-induced disappearance of hepatitis C virus.

Tamori A, Nishiguchi S, Shiomi S, Hayashi T, Kobayashi S, Habu D, Takeda T, Seki S, Hirohashi K, Tanaka H, Kubo S.

Am J Gastroenterol. 2005 Aug;100(8):1748-53.

PMID:
16086711
18.
19.

Prevention of intrahepatic recurrence by adjuvant (131)iodine-labeled lipiodol after resection for hepatocellular carcinoma in HCV-related cirrhosis.

Tabone M, Vigano' L, Ferrero A, Pellerito R, Carbonatto P, Capussotti L.

Eur J Surg Oncol. 2007 Feb;33(1):61-6. Epub 2006 Dec 18.

PMID:
17175128
20.

Clinical significance of TT virus infection in patients with chronic hepatitis C.

Zein NN, Arslan M, Li H, Charlton MR, Gross JB Jr, Poterucha JJ, Therneau TM, Kolbert CP, Persing DH.

Am J Gastroenterol. 1999 Oct;94(10):3020-7.

PMID:
10520863
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk